To validate this hypothesis, our investigation will initially assess clinical-pathological relationships between FGF21 levels and critical disease markers in human PDAC samples, with particular emphasis on associations with the infiltration of immune cells and the degree of fibrosis in the inflammatory microenvironment of pancreatic cancer. Here, FGF21 is linked to pancreatic neoplasm.